- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01091181
The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar
Study Overview
Detailed Description
Having a Caesarean leads to a scar in the uterus, which does not always heal properly. Defective healing can lead to serious complications in the next pregnancy and delivery. Different surgical techniques can be used for a Caesarean section.
The aim is to compare two surgical techniques (different ways of opening the uterus), to investigate whether one or the other technique leads to fewer defective scars in the uterus. Both these techniques are in use at the clinic. After the operation, patients are cared for in the normal way.
Six months after the Caesarean, patients are examined using vaginal ultrasound. Vaginal ultrasound allows to see if the scar after the Caesarean has healed well, or if there are defects in it.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Malmö, Sweden, Se 20502
- Skåne University Hospital Malmö
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
inclusion criteria:
- ≥ 18 years old
- gestational age ≥ 37 gestational weeks
- cervical dilatation ≥5 cm,
- no previous uterine surgery other than cone biopsy, loop electrosurgical excision procedure, dilatation and curettage, or dilatation and evacuation, undergoing emergency caesarean section.
exclusion criteria:
• need of immediate caesarean section, defined as delivery of the baby within 20 minutes.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: high incision group
hysterotomy at cesarean performed 2 cm above plica vesicouterina
|
incision to open the uterus at cesarean.
|
|
ACTIVE_COMPARATOR: low incision group
hysterotomy at cesarean performed 2 cm below plica vesicouterina
|
incision to open the uterus at cesarean.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
large defect
Time Frame: 6 months
|
occurrence of large defects in uterine cesarean scar are detected by ultrasound and are assessed by the percentage of patients who have large defects in uterine cesarean scar
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
APGAR score
Time Frame: 1 and 5 minute after delivery
|
APGAR score measured at 1 and 5 minute after delivery.
The five criteria are summarized using words chosen to form a backronym (Appearance, Pulse, Grimace, Activity, Respiration).The Apgar scale is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained.
The resulting Apgar score ranges from zero to 10.
|
1 and 5 minute after delivery
|
|
blood loss
Time Frame: 1 hour
|
estimated blood loss during surgery is measured in terms of mL
|
1 hour
|
|
difficulties at delivery of fetus
Time Frame: 1 hour
|
difficulties at delivery of fetus at caesarean are assessed by the percentage of patients when surgeons experience difficulties at delivery of fetus at caesarean
|
1 hour
|
|
postoperative infection
Time Frame: 8 weeks
|
postoperative infection after caesarean section is assessed by the percentage of patients who develop this complication
|
8 weeks
|
|
readmission to the hospital
Time Frame: 8 weeks
|
readmission to the hospital due to need of re-operation is assessed by the percentage of patients who have re-operation after caesarean
|
8 weeks
|
|
miscarriage
Time Frame: up to 8 years
|
occurrence of miscarriage in subsequent pregnancy is assessed by the percentage of patients who have miscarriages in subsequent pregnancy
|
up to 8 years
|
|
scar pregnancy
Time Frame: up to 8 years
|
occurrence of scar pregnancy in subsequent pregnancy is assessed by the percentage of patients who have scar pregnancy after the index caesarean
|
up to 8 years
|
|
placenta previa/accreta
Time Frame: up to 8 years
|
occurrence of placenta previa/accreta in subsequent pregnancy is assessed by the percentage of patients who have placenta previa/accreta in subsequent pregnancy
|
up to 8 years
|
|
uterina rupture/uterine dehiscence
Time Frame: up to 8 years
|
occurrence of uterine rupture/uterine dehiscence in subsequent labour is assessed by the percentage of patients who have uterine rupture/uterine dehiscence in subsequent labour
|
up to 8 years
|
|
vaginal delivery after caesarean
Time Frame: up to 8 years
|
success rate of vaginal delivery after caesarean is assessed by the percentage of patients who delivered vaginally after the index caesarean
|
up to 8 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Olga Vikhareva, MD, PhD, Skane University Hospital
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2-valentin
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.